wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28085028-D0C6112A-CFB2-4653-9B45-6D3CB76C0DE2
Q28085028-D0C6112A-CFB2-4653-9B45-6D3CB76C0DE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28085028-D0C6112A-CFB2-4653-9B45-6D3CB76C0DE2
Efavirenz and the CNS: what we already know and questions that need to be answered
P2860
Q28085028-D0C6112A-CFB2-4653-9B45-6D3CB76C0DE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28085028-D0C6112A-CFB2-4653-9B45-6D3CB76C0DE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1caee3e80bd6e79ba69508db12051d8fe51ff194
P2860
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.